Remove 2014 Remove Competition Remove Doctors Remove Healthcare
article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. Biogen’s activity in multiple sclerosis.

article thumbnail

Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland

Evolve Your Success

He also talks about partnering with small businesses and how they are leading the competition in this particular space. Mark Copeland has an experience in medical device sales with 18 years in the game and 27 in healthcare. He brings new products that solve healthcare problems. I find reps, doctors, and directors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Liron Fendell

Cadensee

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. And I was lucky enough the team at Schneider's and Clalit Healthcare , who is the owner of Schneider Hospital. They want it to be backed by doctors. That it is was developed by doctors and backed by doctors.

Retail 52
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. The path to real zero.

article thumbnail

Driving Provider Engagement in Value-Based Care

Clarify Health

And frankly, if you’re paying a provider 57% of the 2014 CMS schedule, they’re not going to be terribly excited about you putting this bonus program in front of them when they’re concentrating on that. We all have to figure out the best way to move forward to keep healthcare costs under control. So we assign them.

article thumbnail

Will A.I. Replace the Medical Sales Workforce and Surgeons? With Edouard Saget

Evolve Your Success

Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The pathways, honestly, if I were to do it again, the first thing I would do is go find a doctor, any of them depending on what the fields are, and then ask for recommendations for who they work with our current sales reps. It was rough.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. These actions allegedly led to the extension of Novartis’ patents. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.